{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:05:32Z","timestamp":1784030732358,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1067\/mjd.2001.113454","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T18:14:26Z","timestamp":1030212866000},"page":"637-638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Optimal treatment for scabies remains undetermined"],"prefix":"10.1067","volume":"45","author":[{"given":"Craig G.","family":"Burkhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig N.","family":"Burkhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2001.113454_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJM199507063330105","article-title":"The treatment of scabies with ivermectin","volume":"333","author":"Meinking","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.113454_bib2","first-page":"67","article-title":"Ectoparasitic diseases in dermatology: reassessment of scabies and pediculosis","volume":"Vol 15","author":"Meinking","year":"1999"},{"key":"10.1067\/mjd.2001.113454_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1525-1470.1999.00124.x","article-title":"Before using ivermectin therapy for scabies","volume":"16","author":"Burkhart","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"10.1067\/mjd.2001.113454_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2307\/3285796","article-title":"Molecular composition of the louse sheath","volume":"85","author":"Burkhart","year":"1999","journal-title":"J Parasitol"},{"key":"10.1067\/mjd.2001.113454_bib5","first-page":"292","article-title":"Ivermectin: an assessment of its pharmacology, microbiology, and safety","volume":"13","author":"Burkhart","year":"2000","journal-title":"Hum Vet Toxicol"},{"key":"10.1067\/mjd.2001.113454_bib6","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4269\/ajtmh.1995.53.652","article-title":"Topical application of ivermectin for human ectoparasites","volume":"53","author":"Youssef","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1067\/mjd.2001.113454_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2885.1990.tb00800.x","article-title":"Pharmacokinetics of ivermectin after oral or percutaneous administration to adult milking goats","volume":"13","author":"Scott","year":"1990","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1067\/mjd.2001.113454_bib8","first-page":"379","article-title":"Topical (pour-on) ivermectin in the treatment of canine scabies","volume":"38","author":"Paradis","year":"1997","journal-title":"Can Vet J"},{"key":"10.1067\/mjd.2001.113454_bib9","first-page":"143","article-title":"Resistance to pyrethroid insecticides in arthropods","author":"Sawicki","year":"1985"},{"key":"10.1067\/mjd.2001.113454_bib10","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jee\/90.6.1478","article-title":"Inheritance of CYP6D1-mediated pyrethroid resistance in house fly (Diptera: Muscidae)","volume":"90","author":"Liu","year":"1997","journal-title":"J Econ Entomol"},{"key":"10.1067\/mjd.2001.113454_bib11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archpedi.153.9.969","article-title":"Differential permethrin susceptibility of head lice sampled in the United States and Borneo","volume":"153","author":"Pollack","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1067\/mjd.2001.113454_bib12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/0190-9622(90)70346-J","article-title":"Scabies in nursing homes: an eradication program with permethrin 5% cream","volume":"23","author":"Yonkosky","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.113454_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archderm.1990.01670260037006","article-title":"Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies","volume":"126","author":"Schultz","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.113454_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1525-1470.1990.tb01078.x","article-title":"Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children","volume":"7","author":"Taplin","year":"1990","journal-title":"Pediatr Dermatol"},{"key":"10.1067\/mjd.2001.113454_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2133.1975.tb03084.x","article-title":"Mites in the environment of cases of Norwegian scabies","volume":"92","author":"Carslaw","year":"1975","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.113454_bib16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0190-9622(88)70237-6","article-title":"Prevalence of Sarcoptes scabiei in the homes and nursing homes of scabietic patients","volume":"19","author":"Arlian","year":"1988","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962201700588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962201700588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:25:39Z","timestamp":1759267539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962201700588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0190962201700588"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2001.113454","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal treatment for scabies remains undetermined","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mjd.2001.113454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}